NASDAQ

Results: 4361



#Item
941Stock market / Corporate finance / Investment / Investor relations

SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011 DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of n

Add to Reading List

Source URL: astx.com

Language: English
942American Association for Cancer Research / Protein kinase inhibitor / Display board / Academia / Poster session / Serine/threonine-specific protein kinase

SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a

Add to Reading List

Source URL: astx.com

Language: English
943Astex

September 4, 2012 Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical co

Add to Reading List

Source URL: astx.com

Language: English
    944Renewable energy / First Solar / Bill Gross / Idealab / Solar panel / Solar tracker / ESolar / Solar cell / Photovoltaic system / Photovoltaics / Technology / Energy

    First Solar Acquires RayTracker Inc. TEMPE, Ariz. – Jan. 7, [removed]First Solar, Inc. (NASDAQ: FSLR) and RayTracker, Inc. today announced that First Solar has acquired RayTracker, Inc., a tracking technology and photovo

    Add to Reading List

    Source URL: www.idealab.com

    Language: English - Date: 2011-01-21 19:12:27
    945Astex

    April 22, 2013 Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th DUBLIN, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company

    Add to Reading List

    Source URL: astx.com

    Language: English
      946Healthcare / Technology / Otolaryngology / Sinusitis / Sinus / Norwest / Medicine / Health / CareFusion

      Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors MENLO PARK, Calif., April 9, [removed]Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with

      Add to Reading List

      Source URL: propelopens.com

      Language: English - Date: 2015-04-09 20:24:03
      947Antiviral drug / Astex / Hepatitis C virus / Allosteric regulation

      Astex Pharmaceuticals to Present a Novel Targeted Approach to the Treatment of HCV at the AASLD Meeting DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to t

      Add to Reading List

      Source URL: astx.com

      Language: English
      948Astex / Eisai

      SuperGen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website DUBLIN, Calif.--(BUSINESS WIRE)-- SuperGen, Inc. (NASDAQ:ASTX) announced that it has officially begun operatin

      Add to Reading List

      Source URL: astx.com

      Language: English
      949Astex

      December 4, 2012 Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicat

      Add to Reading List

      Source URL: astx.com

      Language: English
        950Syndromes / Acute myeloid leukemia / Leukemia / Neutropenia / Thrombocytopenia / Decitabine / Medicine / Oncology / Myelodysplastic syndrome

        Astex Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the

        Add to Reading List

        Source URL: astx.com

        Language: English
        UPDATE